[HIT-GBM: multicenter study of treatment of children with malignant glioma]

Area of Science:

• Pediatric Oncology
• Neuro-oncology
• Clinical Trials

Background:

• Pediatric brain tumors, including glioblastoma and astrocytoma, represent a significant challenge in oncology.
• Current treatment protocols often involve surgery and radiotherapy, with limited efficacy for aggressive subtypes.
• There is a need for innovative therapeutic strategies to improve outcomes for children with these rare and devastating diseases.

Purpose of the Study:

• To evaluate the efficacy and safety of a novel treatment regimen for children diagnosed with specific brain tumors.
• To assess the impact of combining conventional radiotherapy with an experimental chemotherapy combination.

Main Methods:

• A prospective clinical study initiated by the German Society for Paediatric Oncology and Hematology.
• Patients undergo surgery followed by conventional fractionated radiotherapy (54 Gy).
• Simultaneously, an experimental arm involves oral administration of trofosfamide (100 mg/m2/d) and VP16 (25 mg/m2/d), with treatment arms changing every two years.

Main Results:

• This abstract describes the study's initiation and design, not preliminary or final results.
• The study aims to gather data on treatment response, survival rates, and toxicity profiles.

Conclusions:

• The study represents a concerted effort to advance treatment options for pediatric brain tumors.
• Findings are anticipated to inform future therapeutic guidelines and improve patient care.